Small cell lung cancer spreads fast—but it is also treatable. We make use of our entire treatment arsenal to provide our patients with good outcomes. Your treatment may include the latest chemotherapy drugs in combination with immunotherapy. We also offer a wide range of clinical trials that give you access to promising new treatments.
What is small cell lung cancer?
About 13 percent of all lung cancers are small cell lung cancers (SCLC). Smoking is one of the biggest risk factors. There are two main types:
Small cell lung cancer is aggressive—it grows and spreads to other areas of the body more quickly than non-small cell lung cancer. Tumors often metastasize (spread) to the brain, liver, and bones.
Treating lung cancer metastasis to the brain
For small cell lung cancer that has metastasized, we work closely with experts in neuro-oncology, neurosurgery, and radiation oncology to provide the highest quality of care possible. This collaborative approach helps make this complex diagnosis routine, leading to better outcomes.
Sometimes, treatment includes Gamma Knife® therapy. This radiation treatment:
- Targets and removes brain tumors with pinpoint accuracy
- Requires no incisions
- Helps you avoid the risks associated with conventional brain surgery
Our radiation oncologists use this technology to treat many patients with advanced lung cancer that has spread to the brain.
Why choose Penn Medicine for small cell lung cancer care
Our experienced lung cancer specialists were a part of the clinical trials that established the standard of care for small cell lung cancer. They bring that expertise to your bedside, offering the advanced treatments and knowledge needed to provide effective care. We also provide:
- Team-based care: Our lung cancer team collaborates with surgeons, dermatologists, cardiologists, rheumatologists, and neurologists to manage your care and potential side effects.
- Rapid treatment: Because SCLC is so aggressive, our doctors arrange their schedules to better accommodate newly diagnosed patients. Our oncology-certified nurse navigator leads the way in these efforts, coordinating any necessary appointments so you can get into lung cancer treatment faster.
- Comprehensive treatments: We offer the full range of chemotherapy, radiation treatment, and immunotherapy options to treat small cell lung cancer. You also have access to new treatments through lung cancer clinical trials.
- Care close to home: We offer chemotherapy, radiation treatments, and pre- and postoperative care throughout the southeastern Pennsylvania and New Jersey region. Using your zip code, we make sure you’re able to get the care you need where it's most convenient.
Rated “exceptional” by The National Cancer Institute
Penn Medicine’s Abramson Cancer Center is a world leader in cancer research, patient care, and education. Our status as a national leader in cancer care is reflected in our continuous designation as a Comprehensive Cancer Center by the National Cancer Institute (NCI) since 1973, one of 7 such centers in the United States. The ACC is also a member of the National Comprehensive Cancer Network, one of a select few cancer centers in the U.S., that are working to promote equitable access to high-quality, advanced cancer care.